1. Home
  2. STTK vs PESI Comparison

STTK vs PESI Comparison

Compare STTK & PESI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$3.63

Market Cap

119.0M

Sector

Health Care

ML Signal

HOLD

Logo Perma-Fix Environmental Services Inc.

PESI

Perma-Fix Environmental Services Inc.

HOLD

Current Price

$12.65

Market Cap

231.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
STTK
PESI
Founded
2016
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Environmental Services
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
119.0M
231.8M
IPO Year
2020
1992

Fundamental Metrics

Financial Performance
Metric
STTK
PESI
Price
$3.63
$12.65
Analyst Decision
Buy
Analyst Count
5
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
445.0K
102.5K
Earning Date
11-06-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,000,000.00
$60,661,000.00
Revenue This Year
N/A
$9.91
Revenue Next Year
N/A
$62.48
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.69
$6.25
52 Week High
$3.62
$16.50

Technical Indicators

Market Signals
Indicator
STTK
PESI
Relative Strength Index (RSI) 77.52 43.04
Support Level $3.15 $12.50
Resistance Level $3.29 $13.04
Average True Range (ATR) 0.22 0.48
MACD 0.03 -0.12
Stochastic Oscillator 88.64 3.72

Price Performance

Historical Comparison
STTK
PESI

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About PESI Perma-Fix Environmental Services Inc.

Perma-Fix Environmental Services Inc is a provider of both nuclear services and the management of nuclear and mixed waste. The company operates through two segments: The treatment segment offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.

Share on Social Networks: